Acura Pharmaceuticals, Inc. has released an amended loan schedule for a Secured Promissory Note dated November 10, 2022.
The amendment includes additional loans from Loan #1 dated 12/22/2022 to Loan #43.
Robert A. Seiser, Senior Vice President & CFO, signed the amended loan schedule on behalf of Acura Pharmaceuticals, Inc.
Amended Loan Schedule
Includes loans from Loan #1 to Loan #43, expanding the original Secured Promissory Note.
- The amendment signifies Acura Pharmaceuticals' ongoing financial activities and partnerships.
- Expansion to Loan #43 indicates the company's forward-looking financial strategy.
Acura Pharmaceuticals, Inc. continues to strengthen its financial position through additional loan agreements, showcasing strategic financial planning and growth.